ACP Says Its Guidance Against Hydroxychloroquine, Chloroquine for COVID-19 Unlikely to Change
August 14th 2020The American College of Physicians says it no longer plans to update its rapid, living practice points because it doesn’t believe new evidence will support the use of the antiviral medications in the fight against COVID-19.
Read More
C. diff. Infection, Renal Impairment Have Lower Risk of Recurrence if Given Bezlotoxumab
July 14th 2020A new study finds patients with Clostridium difficile infection are more likely to face a recurrence of the infection if they also have renal impairment. However, bezlotoxumab can reduce that risk.
Read More
ACE Inhibitors, ARBs Do Not Worsen COVID-19 Risk
May 29th 2020Early links between heart disease and diabetes and coronavirus severity caused some to fear that the 2 classes of medication might worsen outcomes during the pandemic. A systematic review finds little evidence to back those fears.
Read More